Company · CIK 1018735

# NYMOX PHARMACEUTICAL CORP

| CIK | [1018735](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001018735) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Business address | Quebec, Canada |
| Listed | NYMXF (OTC) |
| First annual or quarterly report | 1998-05-08 |

## Offerings

 5 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-263932 | Shelf Effective | 2022-03-29 | 2022-04-12 | 2 |
| 333-261571 | Shelf Effective | 2021-12-09 | 2022-03-22 | 3 |
| 333-256024 | Shelf Effective | 2021-05-12 | 2021-05-20 | 2 |
| 333-237564 | Shelf Effective | 2020-04-03 | 2020-08-14 | 5 |
| 333-205659 | Shelf Effective | 2015-07-14 | 2016-02-09 | 3 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2022-04-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1018735/999999999522000946/9999999995-22-000946-index.htm) Declared effective | 333-263932 | 9999999995-22-000946 |
| 2022-03-29 | [F-3](https://www.sec.gov/Archives/edgar/data/1018735/000164033422000599/0001640334-22-000599-index.htm) Shelf registered | 333-263932 | 0001640334-22-000599 |
| 2022-03-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1018735/000164033422000556/0001640334-22-000556-index.htm) Shelf takedown | 333-261571 | 0001640334-22-000556 |
| 2022-01-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1018735/999999999522000267/9999999995-22-000267-index.htm) Declared effective | 333-261571 | 9999999995-22-000267 |
| 2021-12-09 | [F-3](https://www.sec.gov/Archives/edgar/data/1018735/000164033421003105/0001640334-21-003105-index.htm) Shelf registered | 333-261571 | 0001640334-21-003105 |
| 2021-05-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1018735/999999999521002045/9999999995-21-002045-index.htm) Declared effective | 333-256024 | 9999999995-21-002045 |
| 2021-05-12 | [F-3](https://www.sec.gov/Archives/edgar/data/1018735/000164033421001119/0001640334-21-001119-index.htm) Shelf registered | 333-256024 | 0001640334-21-001119 |
| 2020-08-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1018735/000164033420002108/0001640334-20-002108-index.htm) Shelf takedown | 333-237564 | 0001640334-20-002108 |
| 2020-08-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1018735/000164033420002102/0001640334-20-002102-index.htm) Shelf takedown | 333-237564 | 0001640334-20-002102 |
| 2020-07-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1018735/000164033420001812/0001640334-20-001812-index.htm) Shelf takedown | 333-237564 | 0001640334-20-001812 |
| 2020-05-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1018735/999999999520001125/9999999995-20-001125-index.htm) Declared effective | 333-237564 | 9999999995-20-001125 |
| 2020-04-03 | [F-3](https://www.sec.gov/Archives/edgar/data/1018735/000164033420000720/0001640334-20-000720-index.htm) Shelf registered | 333-237564 | 0001640334-20-000720 |
| 2016-02-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1018735/000117625616000420/0001176256-16-000420-index.htm) Shelf takedown | 333-205659 | 0001176256-16-000420 |
| 2015-08-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1018735/999999999515002173/9999999995-15-002173-index.htm) Declared effective | 333-205659 | 9999999995-15-002173 |
| 2015-07-14 | [F-3](https://www.sec.gov/Archives/edgar/data/1018735/000117625615000245/0001176256-15-000245-index.htm) Shelf registered | 333-205659 | 0001176256-15-000245 |

[All filings of this company](https://equitycapital.markets/filings?cik=1018735) · [CSV](https://equitycapital.markets/filings.csv?cik=1018735)

---
Source page: https://equitycapital.markets/company/1018735 · Data: U.S. SEC EDGAR · CC BY 4.0